Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-16T21:34:12.264Z Has data issue: false hasContentIssue false

Chapter 26 - Kidney Disease

from Section 2.4 - Urinary Tract Assessment

Published online by Cambridge University Press:  22 June 2017

By
Julie Zemaitis DeCesare
Edited by
David Chelmow ,
Anita Blanchard  and
Lee Learman
David Chelmow
Affiliation:
Virginia Commonwealth University
Anita Blanchard
Affiliation:
University of Chicago
Lee Learman
Affiliation:
Florida Atlantic University
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
The Well-Woman Visit , pp. 171 - 173
Publisher: Cambridge University Press
Print publication year: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Guidelines

Moyer, V.A. Screening for chronic kidney disease: US Preventive Services Task Force recommendation statement. US Preventive Services Task Force. Ann Intern Med. 2012, 157:567–70.Google ScholarPubMed
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39:S1–266.Google Scholar
Qaseem, A., Hopkins, R.H., Sweet, D.E., Starkey, M., and Shekelle, P. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: A clinical practice guideline from the American College of Physicians. Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2013, 159:835–47.Google Scholar
ASN disagrees with new guidelines, says adults should be screened for kidney disease [press release]. Nephrol News Issues [electronic], 2013. Available at: www.nephrologynews.com/articles/109817-asn-disagrees-with-new-guidelines-says-adults-should-be-screened-for-kidney-disease. Retrieved December 23, 2015.Google Scholar

References

United States Renal Data System. Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2014.Google Scholar
Meguid, A., El Nahas, B., and Aminu, K. Chronic kidney disease: The global challenge. Lancet. 2005, 365(9456):331–40.Google Scholar
Fink, H.A., Ishani, A., Taylor, B.C. et al. Chronic Kidney Disease Stages 1–3: Screening, Monitoring, and Treatment. Comparative Effectiveness Review 37. AHRQ Publication 11(12)-EHC075-EF. Rockville, MD: Agency for Healthcare Research and Quality, 2012.Google ScholarPubMed
Fink, H.A., Ishani, A., Taylor, B.C. et al. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: A systematic review for the US Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2012, 156:570–81.CrossRefGoogle ScholarPubMed
Ward, F., Holian, J., and Murray, P. Drug therapies to delay the progression of chronic kidney disease. Clin Med. 2015, 15(6):550–7.CrossRefGoogle ScholarPubMed
Sato, K., Hayashi, T., Uehara, S. et al. Drinking pattern and risk of chronic kidney disease: The Kansai Healthcare Study. Am J Nephrol. 2014, 40(6):516–22.Google Scholar
Wang, H., Hsu, Y.H., Chuang, S.Y. et al. Use of nonsteroidal anti-inflammatory drugs and risk of chronic kidney disease in subjects with hypertension: Nationwide Longitudinal Cohort Study. Hypertension. 2015, 66(3):524–33.Google Scholar
Rovin, B. and Parikh, S. Lupus nephritis: The evolving role of novel therapeutics. Am J Kidney Dis. 2014, 63(4):677–90.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×